BFM
ACHV icon

Boothbay Fund Management’s Achieve Life Sciences ACHV Stock Holding History

Boothbay Fund Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-33,389
Closed -$387K – 1815
2021
Q1 		$387K Hold
33,389
– – 0.01% 1080
2020
Q4 		$270K Hold
33,389
– – 0.01% 989
2020
Q3 		$279K Buy
+33,389
New +$306K 0.02% 827
2016
Q4 		– Sell
-28
Closed -$31K – 733
2016
Q3 		$31K Buy
+28
New +$44.6K 0.01% 692

Other funds holding ACHV

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Boothbay Fund Management's ACHV Position: Q2 2021 in Review

Boothbay Fund Management sold out of Achieve Life Sciences (ACHV) in Q2 2021, closing a stake of 33,389 shares — an estimated $387K sold.

Boothbay Fund Management first reported a position in ACHV in Q3 2016 and held it in 4 quarters. The position peaked at $387K in Q1 2021. 29 funds tracked by Wall St. Rank hold ACHV as of Q2 2021.

  • Boothbay Fund Management reported no remaining Achieve Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 33,389 Achieve Life Sciences shares in Q2 2021, an estimated $387K.
  • Boothbay Fund Management first reported a position in Achieve Life Sciences in Q3 2016 and held it in 4 quarters.
  • Boothbay Fund Management's Achieve Life Sciences position peaked at $387K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2021.

Based on Boothbay Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.